Previous policy statements by CMS have addressed hospice and Part-D sponsor requirements regarding responsibility for the payment of prescription drugs under the Part-A hospice benefit and Part-D. However, CMS has received questions indicating their policy statements are being misinterpreted by some parties. Therefore, in this memorandum, CMS seeks to clarify the criteria for determining payment responsibility for drugs for hospice beneficiaries.
- 6 Dec, 2013
- 0 Comments